Contributions from Improvements in Marketing System Activities by the Pharmaceutical Industry

Journal of Pharmaceutical Marketing and Management

Volumn 14, Issue 42067, 2002, Pages 129-136

  Mccaffrey, David J ^a   Smith, Mickey C ^b  

^a UNIVERSITY OF MISSISSIPPI   (United States)

^b UNIVERSITY OF MISSISSIPPI   (United States)

Author keywords

marketing; marketing system; Pharmaceuticals

Indexed keywords

EID: 85018892272     PISSN: 08837597     EISSN: 15408574     Source Type: Journal    
DOI: 10.3109/J058v14n03_09     Document Type: Article

References (17)

1. Wilkie TL, Moore ES. Marketing's contributions to society. J Marketing. 1999; 63 (Special Issue): 198 – 218.
2. Spilker B. Multinational pharmaceutical companies: Principles and practices. 2nd ed. New York: Raven Press; 1994.
3. The CDER handbook [resource on World Wide Web]. URL: http://www. fda.gov/cder/handbook/index.htm. Accessed 2001 Mar 26.
4. Facts about the pharmaceutical industry [resource on World Wide Web]. URL: http://www.phrma.org/publications/backgrounders/development/invest.phtml. Accessed 2001 Mar 26.
5. Trombetta W, Cavanagh J. Pharmaceutical marketing in transition. J Pharm Market Manage. 1997; 11 (4): 3 – 20.
6. About compounding [resource on World Wide Web]. URL: http://www.pccarx. com/about_comp.htm. Accessed 2001 Mar 26.
7. Sormedecker G, ed. Kremer and Urdang's history of pharmacy. 4th ed. Philadel-phia: J. B. Lippincott; 1976.
8. Sackett DL, Haynes B, eds. Compliance with therapeutic regimens. Baltimore: Johns Hopkins University Press; 1976.
9. Kolassa EM. Elements of pharmaceutical pricing. Binghamton, NY: Haworth Press, Inc.; 1997.
10. Zellmer WA. Rethinking hospital pharmaceutical marketing. Am J Health-Syst Pharm. 1995; 52: 1590.
11. Basara LR, Smith MC. Pharmacist perspectives on patient programs. Pharm Exec. 1995; 15(Nov): 83 – 6.
12. Farmer K, Jacobs E. Pilot study of the impact on patient medication adherence by a company sponsored newsletter compliance program. APhA Annual Meeting 1995; 142(Mar): 24.
13. Casey MM, Maioli CM. Product support: Uplifting patients, payers and provid-ers. Pharm Exec 1996; 16(Feb): 60 – 62, 64, 66.
14. Gale B, Smith P, Wilson, P. Research databases for postmillennium health care. J Pharm Market Manage. 1996; 10(2/3):39 – 59.
15. Morris L. Direct-to-Lou. Pharm Exec. 1999; 19(June Suppl): 20.
16. Hepler CD, Strand LM. Opportunities and responsibilities in pharmaceutical care. Am J Hosp Pharm. 1990; 47: 533 – 43.
17. Zelnio RN, Bertram DK. A pharmaceutical marketing plan for the 21st century: Primary research prospects. J Pharm Market Manage. 1996; 10(2/3):61 – 107.